Intrastriatal grafting of glomus cells ameliorates behavioral defects of Parkinsonian rats

Physiology and Behavior

Volumn 77, Issue 4-5, 2002, Pages 519-525

  Hao, Gang ^a   Yao, Yun ^a   Wang, Junmei ^a   Zhang, Lili ^a   Viroonchatapan, Nitnara ^a   Wang, Zuo Zhong ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Carotid body; Dopamine; Glomus cells; Immortomouse; Parkinson's disease; Rat; Striatum; Substantia nigra; Transplantation

Indexed keywords

DOPAMINE; GAMMA INTERFERON; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID BODY; CELL CLONE; CELL IMMORTALIZATION; CELL ISOLATION; CELL LINE; CELL TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FLOW CYTOMETRY; MOTOR DYSFUNCTION; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SUBSTANTIA NIGRA; TEMPERATURE; TRANSGENIC MOUSE; TREATMENT OUTCOME;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CAROTID BODY; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CELLS, CULTURED; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MICE; MICE, TRANSGENIC; NEOSTRIATUM; NEURONS; PARKINSON DISEASE, SECONDARY; RATS; SENSORY THRESHOLDS; STEREOTYPED BEHAVIOR; VIBRISSAE;

EID: 0036955707     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(02)00938-1     Document Type: Article

References (24)

1. Yurek D.M., Sladek J.R. Jr. Dopamine cell replacement: Parkinson's disease. Annu. Rev. Neurosci. 13:1990;415-440.
2. Rosenthal A. Auto transplants for Parkinson's disease? Neuron. 20:1998;169-172.
3. Bjorklund A., Lindvall O., Isacson O., Brundin P., Wictorin K., Strecker R.E.et al. Mechanisms of action of intracerebral neural grafts: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci. 10:1987;509-516.
4. Fidone S.J., Gonzalez C. Initiation and control of chemoreceptor activity in the carotid body. Fishman A. Handbook of physiology: The respiratory system. vol. II:1986;247-312 Am. Physiol. Soc, Washington (DC).
5. Espejo E.F., Montoro R.J., Armengol J.A., Lopez-Barneo J. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron. 20:1998;197-206.
6. Luquin M.R., Montoro R.J., Guillen J., Saldise L., Insausti R., Del Rio J.et al. Recovery of chronic Parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron. 22:1999;743-750.
7. b-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA. 88:1991;5096-5100.
8. Henry C., Marbrook J., Vann D.C., Kodlin D., Wofsy C. Limiting dilution analysis. Mishell B., Shiigi S.M. Selected methods in cellular immunology. 1980;138-152 W.H. Freeman and Co. San Francisco.
9. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research: Analysis of functional deficits, recovery, and treatments. Prog. Neurobiol. 50:1996;275-331.
10. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;486-493.
11. Kameda Y., Yamatsu Y., Kameya T., Frankfurter A. Glomus cell differentiation in the carotid body region of chick embryos studied by neuron-specific class III beta-tubulin isotype and Leu-7 monoclonal antibodies. J. Comp. Neurol. 348:1994;531-543.
12. Bohn M.C., Cupit L.C., Marciano F., Gash D.M. Adrenal medullary grafts enhance recovery of striatal dopaminergic fibers. Science. 237:1987;913-916.
13. Tomac A., Lindqvist E., Lin L.-F.H., Ogren S.O., Young D., Hoffer B.J.et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
14. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman J.et al. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-254.
15. Lee S.H., Lumelsky N., Studer L., Auerbach J.M., McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 18:2000;675-679.
16. Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., Nakanishi S.et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron. 28:2000;31-40.
17. Hynes M., Rosenthal A. Embryonic stem cells go dopaminergic. Neuron. 28:2000;11-14.
18. Erickson J.T., Conover J.C., Borday V., Champagnat J., Barbacid M., Yancopoulos G.et al. Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J. Neurosci. 16:1996;5361-5371.
19. Wang Z.Z., Dinger B., Fidone S.J., Stensaas L.J. Changes in tyrosine hydroxylase and substance P immunoreactivity in the cat carotid body following chronic hypoxia and denervation. Neuroscience. 83:1998;1273-1281.
20. Davidson B.L., Allen E.D., Kozarsky K.F., Wilson J.M., Roessler B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature (Genetics). 3:1993;219-223.
21. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M.et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
22. Neering S.J., Hardy S.F., Minamoto D., Spratt S.K., Jordan C.T. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood. 88:1996;1147-1155.
23. Hammang J.P., Baetge E.E., Behringer R.R., Brinster R.L., Palmiter R.D., Messing A. Immortalized rat neurons derived from SV40 Tag induced tumors in transgenic mice. Neuron. 4:1990;775-782.
24. Renfranz P.J., Cunningham M.G., McKay R.D.G. Region-specific differentiation of the hippocampal stem cells line HiB5 upon implantation into the developing mammalian brain. Cell. 66:1991;713-729.